Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : License crawled time : 12:01 save search
CuraScientific $600,000 License Purchase to Expand Delivery and Customer Acquisition
Published: 2023-05-31 (Crawled : 12:01) - globenewswire.com
CSTF | $0.0001 0.0% 3.3M
|
Retail Trade
|
| O: 0.0%
H: 16.67%
C: -6.67%
license acquisition
Tonix Pharmaceuticals Licenses Technology for Treating Prader-Willi Syndrome, a Rare Genetic Eating Disorder, from the French National Institute of Health and Medical Research (Inserm)
Published: 2021-02-11 (Crawled : 12:01) - globenewswire.com
TNXP | $0.159 1.27% 1.26% 1.1M
|
Health Technology
|
| O: 9.2%
H: 19.1%
C: 12.36%
genetic license research syndros rare
Tonix Pharmaceuticals Acquires Exclusive License to University of Geneva Technology for Oxytocin-Based Treatments for Treating Insulin Resistance, Diabetes and Obesity, Expanding Proprietary Uses for TNX-1900 (Intranasal Potentiated Oxytocin)
Published: 2020-12-22 (Crawled : 12:01) - globenewswire.com
TNXP | $0.159 1.27% 1.26% 1.1M
|
Health Technology
|
| O: 3.05%
H: 1.28%
C: -2.74%
diabetes obesity license oxytocin insulin potential
Nabriva Therapeutics and Sinovant Sciences Restructure License Agreement for XENLETA for Community-Acquired Bacterial Pneumonia in China
Published: 2020-12-07 (Crawled : 12:01) - globenewswire.com
NBRV | $1.42 1.39% 720K
|
Health Technology
|
| O: 4.05%
H: 3.38%
C: -1.82%
license china acquired
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.